Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Orchard Therapeutics plc - American Depositary Shares (NQ: ORTX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 16.52 (1)
Ask (Size) 17.13 (1)
Prev. Close 16.70
Today's Range N/A - N/A
52wk Range 16.38 - 16.65
Shares Outstanding 184,260,149
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024
Eight presentations showcase the broad applicability of HSC gene therapy to address rare neurometabolic diseases and beyond 
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire

Performance

More News

Read More
Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Orchard Therapeutics: Q3 Earnings Insights
Via Benzinga
Why Orchard Therapeutics Stock Is Soaring Today
Via The Motley Fool
Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy for Eligible Children with Early-onset Metachromatic Leukodystrophy in the U.S.
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLDSymposium
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Orchard Therapeutics Receives Swissmedic Approval for Libmeldy in Early-onset MLD
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Orchard Therapeutics Receives U.S. FDA Fast Track Designation for OTL-203 in MPS-IH
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
ORCHARD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Orchard Therapeutics plc - ORTX
From Kahn Swick & Foti, LLC
Via Business Wire
Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Accomplishments
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Orchard Therapeutics Announces Presentation of Additional Positive Data from Proof-of-concept Study of OTL-203 in MPS-IH at ESGCT 2023
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Orchard Therapeutics Announces Multiple Presentations at ESGCT 2023
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Sarepta Therapeutics Stock Showing Rising Relative Strength
Via Investor's Business Daily
ORCHARD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Orchard Therapeutics plc - ORTX
From Kahn Swick & Foti, LLC
Via Business Wire
Crude Oil Down 2%; ConAgra Brands Earnings Top Views
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Dow Tumbles Over 100 Points; Constellation Brands Raises Profit Forecast
Via Benzinga
Topics Stocks
Exposures US Equities
Highly Rated Biotech Orchard Therapeutics Scores A Takeover, Shares Nearly Double
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SP® Plus Corporation (Nasdaq - SP), Orchard Therapeutics plc (Nasdaq - ORTX), Summit Materials (NYSE - SUM)
From Brodsky & Smith LLC
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.